Biotech Values

[10nisman]

Updated my MNTA model using Rocky's script data:
$246M mL sales
$68M Revenue to MNTA
$0.97 eps

$68M revenue (MNTA's profit share) seems light based on your estimated $246M in mL sales. You seem to be assuming a significant decline in gross margins from Q4'10 (~68.5%) to something around 61.5% in Q1'11. If gross margins in Q1'11 remain equal to Q4'10, MNTA's mL revenue would be ~$75M based on your estimated $246M mL sales.